Essex Bio-Technology Limited (HKG:1061)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.430
+0.010 (0.23%)
At close: Feb 13, 2026

Essex Bio-Technology Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
2,5121,6671,4132,4012,8482,463
Market Cap Growth
57.63%17.98%-41.13%-15.72%15.63%-32.35%
Enterprise Value
2,1601,3941,3492,2722,7532,432
Last Close Price
4.432.862.323.834.413.74
PE Ratio
8.045.435.1310.658.2311.25
Forward PE
7.775.565.566.3911.2611.26
PS Ratio
1.461.000.811.821.742.52
PB Ratio
1.100.790.741.391.641.73
P/TBV Ratio
1.961.411.362.732.642.61
P/FCF Ratio
9.915.154.448.198.9312.19
P/OCF Ratio
6.994.534.176.276.968.23
PEG Ratio
-0.660.660.660.660.66
EV/Sales Ratio
1.260.840.781.721.682.49
EV/EBITDA Ratio
4.943.483.356.766.578.88
EV/EBIT Ratio
5.583.933.847.526.999.67
EV/FCF Ratio
8.524.304.247.758.6312.03
Debt / Equity Ratio
0.130.090.150.280.330.40
Debt / EBITDA Ratio
0.660.460.721.451.342.04
Debt / FCF Ratio
1.150.580.921.671.772.78
Net Debt / Equity Ratio
-0.15-0.18-0.11-0.03-0.06-0.03
Net Debt / EBITDA Ratio
-0.81-0.93-0.55-0.16-0.25-0.13
Net Debt / FCF Ratio
-1.39-1.15-0.69-0.18-0.33-0.18
Asset Turnover
0.550.570.630.470.620.44
Inventory Turnover
2.352.142.071.341.831.32
Quick Ratio
1.721.621.371.811.951.79
Current Ratio
1.901.811.542.162.242.20
Return on Equity (ROE)
14.60%15.18%15.06%13.01%21.89%16.69%
Return on Assets (ROA)
7.83%7.63%7.93%6.77%9.31%6.99%
Return on Invested Capital (ROIC)
16.58%16.81%16.55%15.82%22.89%17.77%
Return on Capital Employed (ROCE)
15.70%15.60%17.40%14.00%18.10%13.90%
Earnings Yield
12.47%18.43%19.48%9.39%12.15%8.89%
FCF Yield
10.09%19.44%22.51%12.22%11.20%8.21%
Dividend Yield
3.16%4.19%3.88%1.70%2.16%1.34%
Payout Ratio
21.73%19.39%14.50%24.19%15.00%13.20%
Buyback Yield / Dilution
4.11%2.24%0.62%0.43%0.21%0.12%
Total Shareholder Return
7.28%6.43%4.50%2.13%2.37%1.46%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.